The Foundation for Angelman Syndrome Therapeutics Australia (or FAST) is an organisation of families and professionals dedicated to finding a cure for Angelman Syndrome and related disorders through funding research, education and advocacy. The Foundation is committed to assisting individuals living with Angelman Syndrome to realise their full potential and quality of life.
Angelman Syndrome (or AS) is a neurodevelopmental disorder affecting approximately 1 in 15,000 live births. Although the cause of AS is known, there are currently no treatments available for this disorder. FAST is committed to funding the research that will lead to treatments and eventually a cure. Learn about Angelman Syndrome and why we believe a cure is within reach....
A Night for the Angels
Compiled from the hugely successful "A Night for the Angels" fundraising Gala held recently in Sydney; this clip provides insight to the hopes and dreams of Angelman Syndrome families in Australia and across the globe and the drive behind the Foundation.
Minocycline Clinical Trial
The Minocycline in the Treatment of Angelman Syndrome study will examine if the off label administration of minocycline will alter the severity of symptoms associated with Angelman Syndrome. Minocycline, an FDA approved antibiotic, is traditionally used to treat bacterial infections in several organ systems.
Minocycline is an approved drug in Australia. FAST Australia is working closely with Dr. Weeber and FAST-US to ensure that this trial & any future trials have the ability to be replicated in Australia if required. You can read more about the trials on our US website here
If you have any questions about what this means to you in Australia please do not hesitate to contact us.
Introducing Australian Scientific Advisory Board
Some of Australia's brightest minds have come together to work collaboratively with our United States SABtowards our common goal for a therapeutic to treat Angelman Syndrome. Read more here....
Slideshow
FAST Australia joins FAST US in the mission to find a therapeutic that will alleviate all symptoms of Angelman Syndrome.
